Word: merck
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...load in women already infected with HPV. According to the study's authors, past trials have suggested that HPV vaccination boosts the body's immune response to infection, and some researchers thought that it might work as a form of therapy for HPV-positive women. Like its cousin, Gardasil (Merck), Cervarix is designed to protect against HPV virus types 16 and 18, which together cause 70% of all cervical cancers. But Hidesheim's study of more than 2,100 women aged 18 to 25 in Costa Rica found that Cervarix - like Gardasil - doesn't fight HPV or change the progression...
...earliest stages. Studies have only just begun on the safety of the vaccine in women older than 26. And, according to GlaxoSmithKline spokeswoman Liad Diamond, studying Cervarix in boys and men is "on the radar screen of the clinical development team" but there is "nothing underway right now." At Merck, clinical trials of Gardasil in males have been ongoing for about a year, and preliminary results show that "immune responses in 9- to 15-year-old boys are consistent with those found in females aged 16 to 23," according to Merck's Kelley Dougherty. Once efficacy data are available, Merck...
Moore's current opponents have tried to launch pre-emptive strikes at the director and his moviemaking practices. On June 13, the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents leading drugmakers such as Eli Lilly, Merck and GlaxoSmithKline, issued a statement dismissing Moore as "a political activist with a track record for sensationalism." PhRMA went on to say "a review of America's health care system should be balanced, thoughtful and well-researched" before adding, "Unfortunately, you won't get that from Michael Moore." America's Health Insurance Plans, whose members include HMOs Aetna and Cigna, handed...
...added that this track record may have helped steer Harvard to further license Whiteside’s lab’s developments. The research obtained from Whitesides’ lab will be developed through Nano-Terra’s existing relationships with large companies such as 3M and Merck KGaA, and with the U.S. government—specifically the Department of Defense. These partnerships are expected to produce products in 18 to 36 months, according to the press release. While many of Harvard’s schools have strict rules about professors partnering with companies that they have a financial...
...agency has not recommended any action based on it. "We've shared what we have, and we've done so in a timely and appropriate way," she says. That may prove to be a key issue as the FDA, scientists, investors and patients weigh their next move on Avandia. Merck's undoing, after all, wasn't just the data; it was concerns over the disclosure of it. Says Nissen: "There will be a lot of questions about who knew what, when...